Canmab 440 Mg Injection
- Manufactured by: Biocon
- Contains / Salt: Trastuzumab (440 mg)
Canmab 440 Mg Injection
Prescription Required
179 people have bought this recently
Canmab 440 Mg Injection Information
Canmab 440 Mg Injection is a prescription drug, available for use as Injection. It is primarily used for the treatment of Breast Cancer. Other than this, Canmab 440 Mg Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Canmab 440 Mg Injection is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Canmab 440 Mg Injection also has some side effects, the most common being Insomnia, Infection, Upper respiratory tract infection. Some other side effects of Canmab 440 Mg Injection have been listed ahead. Normally, these side effects of Canmab 440 Mg Injection are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Canmab 440 Mg Injection's effect during pregnancy is Severe and Severe while nursing. In addition, Canmab 440 Mg Injection's effects on the liver, heart and kidney are discussed below in the Canmab 440 Mg Injection related warnings section.
Individuals suffering from medical conditions like Asthma, COPD (Chronic Obstructive Pulmonary Disease), Pneumonitis must refrain from the use of Canmab 440 Mg Injection since this can cause severe adverse effects. Some other conditions that can be affected by Canmab 440 Mg Injection are listed in the contraindications section below.
Drug interactions for Canmab 440 Mg Injection have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Canmab 440 Mg Injection is not safe while driving, and is is not addictive in nature.
Canmab 440 Mg Injection Benefits & Uses
Canmab 440 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
- Gastric Cancer
Canmab 440 Mg Injection Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Canmab 440 Mg Injection Side Effects
Based on research, the following side effects have been observed when Canmab 440 Mg Injection is used -
Severe
- थकान
- बुखार (और पढ़ें - बुखार उतारने के घरेलू उपाय)
- एनीमिया (और पढ़ें - एनीमिया के घरेलू उपाय)
- ठंड लगना
- सफेद रक्त कोशिका गिनती में कमी (न्यूट्रफिल्स)
Mild
- मतली या उलटी
- सिरदर्द
- लाल चकत्ते
- खांसी
- वजन घटना
- दुर्बलता
- जोड़ों का दर्द
- कमर दर्द (और पढ़ें - कमर दर्द के घरेलू उपाय)
- पेट दर्द
Common
- अनिद्रा
- संक्रमण
- उपरी श्वसन पथ का संक्रमण
Canmab 440 Mg Injection Related Warnings
-
Is the use of Canmab 440 Mg Injection safe for pregnant women?
Canmab can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Severe -
Is the use of Canmab 440 Mg Injection safe during breastfeeding?
Canmab should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
Severe -
What is the effect of Canmab 440 Mg Injection on the Kidneys?
Canmab is completely safe for kidneys.
Safe -
What is the effect of Canmab 440 Mg Injection on the Liver?
Using Canmab does not have any harmful effects on the liver.
Safe -
What is the effect of Canmab 440 Mg Injection on the Heart?
The heart can be affected by Canmab. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Moderate
Severe Interaction of Canmab 440 Mg Injection with Other Drugs
Canmab 440 Mg Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Canmab 440 Mg Injection Contraindications
If you are suffering from any of the following diseases, you should not take Canmab 440 Mg Injection unless your doctor advises you to do so -
- Angioedema
- Asthma
- COPD (Chronic Obstructive Pulmonary Disease)
- Pneumonitis
- Heart Disease
- Gastritis
- Pneumonia
Frequently asked Questions about Canmab 440 Mg Injection
-
Is this Canmab 440 Mg Injection habit forming or addictive?
No, there is no any evidence that Canmab 440 Mg Injection is addictive.
No -
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Canmab 440 Mg Injection. So it is best to avoid driving.
Dangerous -
Is it safe?
Canmab 440 Mg Injection is safe but it is important to consult a doctor before taking it.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
No, Canmab 440 Mg Injection is not used to treat mental disorders.
No
Canmab 440 Mg Injection Interactions with Food and Alcohol
-
Interaction between Food and Canmab 440 Mg Injection
It is safe to take Canmab 440 Mg Injection with food.
Safe -
Interaction between Alcohol and Canmab 440 Mg Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Canmab 440 Mg Injection.
Unknown
See all substitutes for Canmab
- Eleftha 440 Mg Injection - ₹18995.25
- Trastuzumab Injection - ₹59400.0
- Herclon Injection - ₹46309.34
- Trasturel 150 Mg Injection - ₹16940.0
- Trasturel 440 Mg Injection - ₹42792.48
- Canmab 150 Mg Injection - ₹21430.5
- Hertraz 150 Injection - ₹19500.0
- Hertraz 440 Injection - ₹58820.0
- Biceltis Injection - ₹75000.0
- Canmab 440 Mg Injection - ₹59981.6
- Vivitra 150 Injection - ₹22447.0
- Vivitra 440 Injection - ₹61132.12
This medicine data has been created by -

B.Pharma, Pharmacy
3 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Herceptin® (trastuzumab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 114-116